BRPI1009468A2 - formulações galênicas de compostos orgânicos - Google Patents
formulações galênicas de compostos orgânicosInfo
- Publication number
- BRPI1009468A2 BRPI1009468A2 BRPI1009468A BRPI1009468A BRPI1009468A2 BR PI1009468 A2 BRPI1009468 A2 BR PI1009468A2 BR PI1009468 A BRPI1009468 A BR PI1009468A BR PI1009468 A BRPI1009468 A BR PI1009468A BR PI1009468 A2 BRPI1009468 A2 BR PI1009468A2
- Authority
- BR
- Brazil
- Prior art keywords
- organic compounds
- galenic formulations
- galenic
- formulations
- compounds
- Prior art date
Links
- 238000009472 formulation Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 150000002894 organic compounds Chemical class 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Diabetes (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Psychiatry (AREA)
- Emergency Medicine (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US16189109P | 2009-03-20 | 2009-03-20 | |
| PCT/US2010/027757 WO2010107971A1 (en) | 2009-03-20 | 2010-03-18 | Galenical formulations of a fixed dose combination of valsartan and aliskiren |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI1009468A2 true BRPI1009468A2 (pt) | 2016-03-01 |
Family
ID=42594917
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI1009468A BRPI1009468A2 (pt) | 2009-03-20 | 2010-03-18 | formulações galênicas de compostos orgânicos |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20120009257A1 (pt) |
| EP (1) | EP2408427A1 (pt) |
| JP (1) | JP2012520895A (pt) |
| KR (1) | KR20110130491A (pt) |
| CN (1) | CN102348452A (pt) |
| AR (1) | AR075880A1 (pt) |
| AU (1) | AU2010226620A1 (pt) |
| BR (1) | BRPI1009468A2 (pt) |
| CA (1) | CA2755487A1 (pt) |
| MX (1) | MX2011009846A (pt) |
| RU (1) | RU2011142081A (pt) |
| TW (1) | TW201039866A (pt) |
| WO (1) | WO2010107971A1 (pt) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6272561B2 (ja) * | 2014-08-29 | 2018-01-31 | デュシネイ・インコーポレイテッド | ドキシラミン並びにピリドキシン及び/またはそれらの代謝産物もしくは塩の多峰性放出製剤 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MY119161A (en) | 1994-04-18 | 2005-04-30 | Novartis Ag | Delta-amino-gamma-hydroxy-omega-aryl-alkanoic acid amides with enzyme especially renin inhibiting activities |
| US8168616B1 (en) | 2000-11-17 | 2012-05-01 | Novartis Ag | Combination comprising a renin inhibitor and an angiotensin receptor inhibitor for hypertension |
| AR048431A1 (es) | 2004-03-17 | 2006-04-26 | Novartis Ag | Formulaciones galenicas de compuestos organicos |
| CN101808631A (zh) * | 2007-09-28 | 2010-08-18 | 诺瓦提斯公司 | 阿利吉仑和缬沙坦的盖仑制剂 |
| WO2009040427A1 (en) * | 2007-09-28 | 2009-04-02 | Novartis Ag | Galenical formulations of organic compounds |
| PT2205279E (pt) * | 2007-09-28 | 2011-07-11 | Novartis Ag | Associação farmacêutica de aliscireno e valsartan |
| AR073651A1 (es) * | 2008-09-24 | 2010-11-24 | Novartis Ag | Formulaciones galenicas de compuestos organicos |
| WO2010107966A1 (en) * | 2009-03-20 | 2010-09-23 | Novartis Ag | Pharmaceutical composition comprising aliskiren |
| US9959508B2 (en) | 2014-03-20 | 2018-05-01 | CloudMade, Inc. | Systems and methods for providing information for predicting desired information and taking actions related to user needs in a mobile device |
-
2010
- 2010-03-18 US US13/256,454 patent/US20120009257A1/en not_active Abandoned
- 2010-03-18 JP JP2012500951A patent/JP2012520895A/ja active Pending
- 2010-03-18 CN CN2010800113847A patent/CN102348452A/zh active Pending
- 2010-03-18 AR ARP100100865A patent/AR075880A1/es unknown
- 2010-03-18 KR KR1020117024606A patent/KR20110130491A/ko not_active Withdrawn
- 2010-03-18 MX MX2011009846A patent/MX2011009846A/es not_active Application Discontinuation
- 2010-03-18 RU RU2011142081/15A patent/RU2011142081A/ru not_active Application Discontinuation
- 2010-03-18 BR BRPI1009468A patent/BRPI1009468A2/pt not_active Application Discontinuation
- 2010-03-18 EP EP10722811A patent/EP2408427A1/en not_active Withdrawn
- 2010-03-18 WO PCT/US2010/027757 patent/WO2010107971A1/en not_active Ceased
- 2010-03-18 CA CA2755487A patent/CA2755487A1/en not_active Abandoned
- 2010-03-18 AU AU2010226620A patent/AU2010226620A1/en not_active Abandoned
- 2010-03-19 TW TW099108212A patent/TW201039866A/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| TW201039866A (en) | 2010-11-16 |
| MX2011009846A (es) | 2011-09-29 |
| CA2755487A1 (en) | 2010-09-23 |
| AR075880A1 (es) | 2011-05-04 |
| AU2010226620A1 (en) | 2011-09-22 |
| CN102348452A (zh) | 2012-02-08 |
| US20120009257A1 (en) | 2012-01-12 |
| RU2011142081A (ru) | 2013-04-27 |
| KR20110130491A (ko) | 2011-12-05 |
| JP2012520895A (ja) | 2012-09-10 |
| WO2010107971A1 (en) | 2010-09-23 |
| EP2408427A1 (en) | 2012-01-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI1007452A2 (pt) | formulações galênicas de compostos orgânicos | |
| BRPI0817442A2 (pt) | Formulações galênicas de composto orgânicos | |
| HRP20181347T1 (hr) | Formulacije dvoslojne tablete | |
| BRPI1012247A2 (pt) | compostos inseticidas | |
| SMT201600008B (it) | Composti di piridazinone | |
| BRPI1015931A2 (pt) | Compostos inseticidas | |
| BRPI1011587A2 (pt) | compostos e composições terapèuticas | |
| LT3403654T (lt) | Geriamosios kortikosteroido kompozicijos | |
| LT3061445T (lt) | Labai koncentruotos farmacinės kompozicijos | |
| BRPI1013614A2 (pt) | compostos substituídos de espiro-amida | |
| BRPI1012539A2 (pt) | composições farmacêuticas | |
| BRPI0715621A2 (pt) | Formulações galênicas de compostos orgânicos | |
| PT2260053E (pt) | Análogos de oxitocina | |
| BR112012003868A2 (pt) | Compostos orgânicos | |
| BRPI1009465A2 (pt) | Formulação | |
| BRPI1013941A2 (pt) | compostos inseticidas | |
| HUE052508T2 (hu) | Szerves anyagból származó illékony szerves vegyületek elnyelése | |
| IT1394400B1 (it) | Composizioni farmaceutiche | |
| SMT201600031B (it) | Composti eterociclici di fenossimetile | |
| PT2402012E (pt) | Formulações líquidas de fumarato de rupatadina | |
| BRPI0917210A2 (pt) | exoterma controlada de formulações de cianocrilato | |
| SMT201500268B (it) | Derivato di 5-idrossipirimidin-4-carbossammide | |
| HUE054030T2 (hu) | Fejlesztett formulációk | |
| BR112012001340A2 (pt) | composições farmacêuticas | |
| CU23884B1 (es) | Derivados de dibenzotiazepina |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B11A | Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing | ||
| B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] | ||
| B350 | Update of information on the portal [chapter 15.35 patent gazette] |